Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
FTXH
FTXH
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
FTXH News
Pharma ETF (FTXH) Reaches Record 52-Week Peak
Nov 19 2025
NASDAQ.COM
Eli Lilly Dominance: The Impact of a Single Stock on Pharma ETF Performance
Nov 15 2025
Benzinga
Pharma ETFs Gain Attention After Strong Q3 Earnings Reports
Nov 14 2025
NASDAQ.COM
Eli Lilly CEO Criticizes PBM 'Rent-Seeking', Claims They Increased Insulin List Prices to $275: 'We Can Easily Bypass Them'
Nov 12 2025
Benzinga
Economist Warns Trump's Full Drug Tariff Will Burden Americans, Not Foreign Companies
Sep 29 2025
Benzinga
Mark Cuban Reveals How Wholesalers Coerce Pharmacies into Nearly Exclusive Agreements, Highlighting PBMs' 'Stranglehold' on Medication Costs
Sep 08 2025
Benzinga
Mark Cuban Says Cutting PBM Fees Won't Reduce Pharmaceutical R&D Funding: 'Manufacturers Can Sell To Us For More'
Aug 01 2025
Benzinga
Trump's Pharma Tariffs Can Hit Novo Nordisk, Says Barclays Expert, But It's 'Difficult' To Predict As Drugmakers Have 'Complex Supply Chains'
Jul 16 2025
Benzinga
Trump Threatens 200% Pharma Tariffs, But Analyst Says This Stock Is Immune And Expected To 'Benefit' From Levies
Jul 11 2025
Benzinga
Mark Cuban Corrects Elizabeth Warren As She Slams JNJ, PFE For Higher Prices And Zero Taxes On Big Pharma: 'PBMs Corrupt Healthcare'
Jun 20 2025
Benzinga
Trump's Drug Price Order Hits PBMs Hardest: CVS, Cigna, UNH In Focus As Experts Highlight 'Racket,' Pricing Distortion
May 19 2025
Benzinga
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Apr 11 2025
Benzinga
Federal Judge Halts National Institutes of Health's Grant Policy Overhaul Citing Legal Violations
Mar 06 2025
Benzinga
What Are Wall Street Analysts' Target Price for Bristol-Myers Squibb Stock?
Jan 31 2025
NASDAQ.COM
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Jan 08 2025
Benzinga
FDA Set To Approve COVID-19 Vaccines As Soon As This Week: Stocks, ETFs To Watch
Aug 19 2024
Benzinga
Show More News
